DNAnexus Partners With QIAGEN to Integrate Its Cloud Genomics Platform With Ingenuity Variant Analysis
Cloud genomics platform facilitates end-to-end solution for clinical research
Cloud genomics platform facilitates end-to-end solution for clinical research
Booth 1415
by John Collings, Global Product Manager, General Purpose Centrifuges at Thermo Fisher Scientific
Protein supplement for gamete and embryo manipulation in assisted reproduction
KEYTRUDA is Merck's anti-PD-1 therapy for metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy
Inexpensive and accurate analysis of mother’s milk fat and calories ideal for neonatal ICU
Researchers present data at breast cancer symposium showing MammaPrint/BluePrint can identify women who benefit from chemotherapy and targeted dual anti-HER2 drug treatment before surgery
Discover our latest clinical content
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies
Biomedical scientists from around the world congregate at the IBMS Congress
Smokers who survive their habit into old age may hold the key to better lung health for all, according to a study funded by the Medical Research Council (MRC)
Dr Emilio Diez-Monedero explains the current approach to molecular drug discovery and gives SelectScience a sneak peek into the SLAS Spanish Drug Discovery Network Meeting
The new Altair™ 240 fully automated analyzer designed with Stanbio chemistry products in mind
Through advanced genetic algorithms and supercomputing, scientists have discovered how genetic diseases such as cancer systematically attack the networks controlling human cells, according to a pair of papers published back-to-back in CELL.
90% chance of anemia in ICU patients after 3 days - diagnostic blood sampling a key factor